vs

Side-by-side financial comparison of 1stdibs.com, Inc. (DIBS) and NEKTAR THERAPEUTICS (NKTR). Click either name above to swap in a different company.

1stdibs.com, Inc. is the larger business by last-quarter revenue ($23.0M vs $21.8M, roughly 1.1× NEKTAR THERAPEUTICS). 1stdibs.com, Inc. runs the higher net margin — -4.5% vs -165.4%, a 160.9% gap on every dollar of revenue. On growth, 1stdibs.com, Inc. posted the faster year-over-year revenue change (0.9% vs -25.3%). 1stdibs.com, Inc. produced more free cash flow last quarter ($3.6M vs $-65.0M). Over the past eight quarters, 1stdibs.com, Inc.'s revenue compounded faster (2.0% CAGR vs 0.4%).

1stdibs.com, Inc. is an American e-commerce company. It has an online marketplace, which sells luxury items such as high-end furniture for interior design, fine art and jewelry. The company has been recognized for "pushing the antiques business into the 21st century." Originally, founded in Paris, it is headquartered in New York City.

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, e...

DIBS vs NKTR — Head-to-Head

Bigger by revenue
DIBS
DIBS
1.1× larger
DIBS
$23.0M
$21.8M
NKTR
Growing faster (revenue YoY)
DIBS
DIBS
+26.1% gap
DIBS
0.9%
-25.3%
NKTR
Higher net margin
DIBS
DIBS
160.9% more per $
DIBS
-4.5%
-165.4%
NKTR
More free cash flow
DIBS
DIBS
$68.6M more FCF
DIBS
$3.6M
$-65.0M
NKTR
Faster 2-yr revenue CAGR
DIBS
DIBS
Annualised
DIBS
2.0%
0.4%
NKTR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DIBS
DIBS
NKTR
NKTR
Revenue
$23.0M
$21.8M
Net Profit
$-1.0M
$-36.1M
Gross Margin
73.5%
Operating Margin
-10.1%
-126.9%
Net Margin
-4.5%
-165.4%
Revenue YoY
0.9%
-25.3%
Net Profit YoY
80.0%
-596.9%
EPS (diluted)
$-0.02
$-4.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DIBS
DIBS
NKTR
NKTR
Q4 25
$23.0M
$21.8M
Q3 25
$22.0M
$11.8M
Q2 25
$22.1M
$11.2M
Q1 25
$22.5M
$10.5M
Q4 24
$22.8M
$29.2M
Q3 24
$21.2M
$24.1M
Q2 24
$22.2M
$23.5M
Q1 24
$22.1M
$21.6M
Net Profit
DIBS
DIBS
NKTR
NKTR
Q4 25
$-1.0M
$-36.1M
Q3 25
$-3.5M
$-35.5M
Q2 25
$-4.3M
$-41.6M
Q1 25
$-4.8M
$-50.9M
Q4 24
$-5.2M
$7.3M
Q3 24
$-5.7M
$-37.1M
Q2 24
$-4.4M
$-52.4M
Q1 24
$-3.3M
$-36.8M
Gross Margin
DIBS
DIBS
NKTR
NKTR
Q4 25
73.5%
Q3 25
74.3%
Q2 25
71.8%
Q1 25
72.4%
Q4 24
72.3%
72.7%
Q3 24
71.0%
81.6%
Q2 24
71.7%
58.5%
Q1 24
72.5%
60.6%
Operating Margin
DIBS
DIBS
NKTR
NKTR
Q4 25
-10.1%
-126.9%
Q3 25
-21.3%
-268.6%
Q2 25
-25.8%
-324.2%
Q1 25
-27.7%
-425.8%
Q4 24
-30.6%
49.2%
Q3 24
-34.9%
-142.4%
Q2 24
-29.2%
-211.9%
Q1 24
-24.3%
-163.7%
Net Margin
DIBS
DIBS
NKTR
NKTR
Q4 25
-4.5%
-165.4%
Q3 25
-16.0%
-301.3%
Q2 25
-19.5%
-372.2%
Q1 25
-21.3%
-486.4%
Q4 24
-22.9%
24.9%
Q3 24
-26.8%
-153.6%
Q2 24
-20.0%
-222.9%
Q1 24
-15.0%
-170.1%
EPS (diluted)
DIBS
DIBS
NKTR
NKTR
Q4 25
$-0.02
$-4.67
Q3 25
$-0.10
$-1.87
Q2 25
$-0.12
$-2.95
Q1 25
$-0.14
$-0.24
Q4 24
$-0.14
$-2.07
Q3 24
$-0.15
$-2.66
Q2 24
$-0.12
$-3.76
Q1 24
$-0.08
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DIBS
DIBS
NKTR
NKTR
Cash + ST InvestmentsLiquidity on hand
$22.9M
$15.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$93.6M
$89.8M
Total Assets
$132.1M
$280.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DIBS
DIBS
NKTR
NKTR
Q4 25
$22.9M
$15.1M
Q3 25
$19.9M
$41.0M
Q2 25
$22.4M
$43.0M
Q1 25
$20.3M
$38.9M
Q4 24
$26.0M
$44.3M
Q3 24
$22.0M
$30.1M
Q2 24
$23.8M
$27.9M
Q1 24
$33.7M
$48.6M
Stockholders' Equity
DIBS
DIBS
NKTR
NKTR
Q4 25
$93.6M
$89.8M
Q3 25
$94.0M
$85.1M
Q2 25
$94.9M
$-24.2M
Q1 25
$96.2M
$13.7M
Q4 24
$99.3M
$60.7M
Q3 24
$107.2M
$48.9M
Q2 24
$110.4M
$79.7M
Q1 24
$131.0M
$126.7M
Total Assets
DIBS
DIBS
NKTR
NKTR
Q4 25
$132.1M
$280.4M
Q3 25
$135.2M
$301.3M
Q2 25
$138.6M
$207.5M
Q1 25
$142.5M
$256.2M
Q4 24
$145.8M
$303.9M
Q3 24
$154.4M
$308.0M
Q2 24
$157.6M
$343.3M
Q1 24
$179.5M
$396.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DIBS
DIBS
NKTR
NKTR
Operating Cash FlowLast quarter
$4.3M
$-65.0M
Free Cash FlowOCF − Capex
$3.6M
$-65.0M
FCF MarginFCF / Revenue
15.7%
-298.0%
Capex IntensityCapex / Revenue
2.9%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-3.2M
$-208.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DIBS
DIBS
NKTR
NKTR
Q4 25
$4.3M
$-65.0M
Q3 25
$-1.5M
$-48.8M
Q2 25
$-5.1M
$-45.7M
Q1 25
$-96.0K
$-49.1M
Q4 24
$2.8M
$-46.2M
Q3 24
$-3.0K
$-43.9M
Q2 24
$-2.6M
$-37.7M
Q1 24
$-3.1M
$-47.9M
Free Cash Flow
DIBS
DIBS
NKTR
NKTR
Q4 25
$3.6M
$-65.0M
Q3 25
$-1.5M
$-48.9M
Q2 25
$-5.2M
$-45.8M
Q1 25
$-143.0K
$-49.1M
Q4 24
$1.5M
$-46.6M
Q3 24
$-44.0K
$-44.6M
Q2 24
$-3.0M
$-37.9M
Q1 24
$-3.3M
$-48.0M
FCF Margin
DIBS
DIBS
NKTR
NKTR
Q4 25
15.7%
-298.0%
Q3 25
-6.8%
-414.5%
Q2 25
-23.4%
-409.6%
Q1 25
-0.6%
-469.0%
Q4 24
6.5%
-159.9%
Q3 24
-0.2%
-184.9%
Q2 24
-13.5%
-161.3%
Q1 24
-14.8%
-222.0%
Capex Intensity
DIBS
DIBS
NKTR
NKTR
Q4 25
2.9%
0.1%
Q3 25
0.1%
1.0%
Q2 25
0.2%
0.3%
Q1 25
0.2%
0.0%
Q4 24
5.8%
1.6%
Q3 24
0.2%
2.8%
Q2 24
1.6%
0.8%
Q1 24
0.9%
0.7%
Cash Conversion
DIBS
DIBS
NKTR
NKTR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-6.36×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons